All About Skin Cancer

There is a finding that the disease modifying drug Methotrexate (MTX), may be carcinogenic.

Methotraxate is usually administered to people with rheumatoid arthritis, a chronic inflammatory disease which affects 1 percent of adults worldwide. Rheumatoid arthritis often leads to disability and eventually a diminished quality of life, it can also cause an early death as one who acquires it is more to developing cancer.

MTX is believed to be carcinogenic because of numerous reports about patients getting lymphoma after being treated by MTX. And the surprising thing is, tumors disappeared when the patients stopped taking the drug.
However, as of this moment studies about Methitrexate have yet to have a conclusion.